Caricamento...

14-3-3ζ Mediates Resistance of Diffuse Large B Cell Lymphoma to an Anthracycline-based Chemotherapeutic Regimen

Patients presenting with diffuse large B cell lymphoma (DLBCL) are treated with a standard anthracycline-based chemotherapeutic mixture consisting of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Half of DLBCL patients will develop chemo-refractory tumors due to the emergence of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Maxwell, Steve A., Li, Zenggang, Jaya, David, Ballard, Scott, Ferrell, Jay, Fu, Haian
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Biochemistry and Molecular Biology 2009
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2755960/
https://ncbi.nlm.nih.gov/pubmed/19525224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M109.022418
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !